La Prairie, Canada

Paul Nguyen Ba

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Nguyen Ba. Retrieved from https://idiyas.com/inventor/paul-nguyen-ba-vmko1ghy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Nguyen Ba: Innovator in Antiviral Compounds

Introduction

Paul Nguyen Ba is a notable inventor based in La Prairie, Canada. He has made significant contributions to the field of antiviral treatments through his innovative research and development of pharmaceutical compounds.

Latest Patents

Paul Nguyen Ba holds a patent for "Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties." This patent discloses compounds of the formula wherein R is hydrogen or an acyl group having 1 to 16 carbon atoms. The patent also describes processes for and intermediates used in the preparation of these compounds, as well as pharmaceutical compositions containing them. These compounds are intended for use in the antiviral treatment of mammals.

Career Highlights

Paul Nguyen Ba is associated with Glaxo Wellcome Inc., a leading pharmaceutical company known for its commitment to research and development in healthcare. His work focuses on creating effective antiviral agents that can significantly impact public health.

Collaborations

Paul collaborates with Pierrette Belleau, who serves as the Legal Representative. Their partnership is essential in navigating the complexities of patent law and ensuring the protection of their innovative work.

Conclusion

Paul Nguyen Ba's contributions to antiviral research exemplify the importance of innovation in the pharmaceutical industry. His work not only advances scientific knowledge but also holds the potential to improve health outcomes for many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…